News Oct 27, 2021 ONWARD Medical goes public and raises CHF 93 million EPFL spin-off ONWARD Medical went public on Euronext Brussels with a secondary listing on Euronext Amsterdam, bringing the value of the company t...
Press Release Mar 08, 2022 Switzerland Global Enterprise and Switzerland Tourism attract innovative companies to Switzerland As a location for innovation, Switzerland is predestined for the development of new business models with future technologies. The settlement of i...
News Oct 13, 2021 Thermo Fisher Scientific opens biologics manufacturing site in Lengnau, Switzerland Thermo Fisher’s new Swiss site – consisting of a 1.5 million square-foot biologics facility with up to 12,500 liters of bioreactor capacity – wil...
News Mar 02, 2022 Vaccines unique to each patient and cancer are being tested at the CHUV Two clinical trials on anti-cancer vaccines have just started at the Lausanne University Hospital (CHUV). Their groundbreaking nature could revol...
S-GE Event Tomorrow's Health: Meet the Experts on Patient Data, Empowerment & Blockchain Jun 17, 2021 Jun 17, 2021 Switzerland
News Feb 09, 2022 ADC Therapeutics secures USD 30 million in new partnership deal ADC Therapeutics’ new partnership will focus on the development and commercialization of ZYNLONTA in Japan, for which the Vaud-based company will...
News Jul 21, 2021 A serological test to assess immunity against SARS-CoV-2 CHUV and EPFL have joined forces to develop a new and particularly accurate serological test to quantify neutralizing antibodies against SARS-CoV...
News Oct 27, 2021 Eye surgery start-up Optimo Medical secures an additional CHF 1.8 million Medtech company Optimo Medical has obtained more funds in a growth financing round to expand its product portfolio in eye surgery planning.
News Feb 09, 2021 Biopôle to welcome three new buildings dedicated to life sciences by 2024 Biopôle SA continues its expansion with the construction of three new buildings. By 2024, an additional 23’000 square meters of office and labora...
Success stories Apr 21, 2021 Deloitte’s Future of Health Initiative: “We have all of the parts of the value chain here, from R&D to manufacturing to commercialization.“ Switzerland is an important hub for the life sciences industry. It is the second largest exporter of packaged medicines in the world and home to ...
News Aug 26, 2020 The Bern Center for Precision Medicine advances personalized therapies for cancer patients Researchers at the Bern Center for Precision Medicine have discovered which genes play an important role in patients’ various responses to radiat...
News Sep 27, 2021 New offering for digital health start-ups in the Basel Area Basel Area Business & Innovation is expanding the offering of its DayOne Accelerator – both in terms of content and the area it covers. As such, ...
News Mar 08, 2021 Debiopharm enters EUR 900+ million contract with Merck Debiopharm has granted a worldwide exclusive license to pharma giant Merck for the development and commercialization of its Xevinapant head and n...
News Dec 11, 2020 Patients stand to benefit from innovative tech project The investment and innovation promotion agency Basel Area Business & Innovation is joining forces with several partners to realize a technolo...
News Oct 27, 2020 CERN and EPFL could revolutionize the future of cancer treatment The GaToroid doctoral research project, conducted jointly by CERN and EPFL, has led to the development of a new machine that uses a cutting-edge ...
News Aug 10, 2021 Women’s health biopharmaceutical company ObsEva receives USD 500 million ObsEva, a Geneva-based biopharmaceutical company dedicated to improving women’s reproductive health, will receive up to USD 500 million for the l...
News Jun 02, 2021 Eye diseases detection specialist EarlySight secures CHF 2.3 million EPFL spin-off EarlySight has secured CHF 2.3 million for the development of a medical device that helps doctors detect and treat eye diseases at ...